18F-DCFPyL-PSMA
Showing 1 - 25 of 1,754
Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))
Not yet recruiting
- Prostate Cancer
- Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
- (no location specified)
Jan 26, 2023
Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)
Recruiting
- Breast Cancer
- +2 more
-
Madison, WisconsinUniversity of Wisconsin School of Medicine and Public Health
Oct 18, 2022
Carcinoma of Prostate Trial in Toronto (18F-DCFPyL)
Active, not recruiting
- Carcinoma of Prostate
- 18F-DCFPyL
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 31, 2022
Prostate Cancer Diagnosis Trial in Los Angeles (diagnostic test, other, drug)
Not yet recruiting
- Prostate Cancer Diagnosis
- PSMA PET scan
- +2 more
-
Los Angeles, CaliforniaVA Greater Los Angeles Healthcare System
Apr 20, 2023
Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,
Enrolling by invitation
- Prostate Neoplasms
- +4 more
- 18F-DCFPyL
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)
Active, not recruiting
- Prostate Cancer
- 18F-DCFPyL Injection
-
Baltimore, MarylandSKCCC
Apr 5, 2022
Prostate Carcinoma Trial in Chicago (Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol)
Not yet recruiting
- Prostate Carcinoma
- Fluorine F 18 DCFPyL
- +6 more
-
Chicago, IllinoisNorthwestern University
Aug 2, 2022
Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)
Not yet recruiting
- Castration Resistant Prostate Cancer
- Castration Sensitive Prostate Cancer
- Piflufolastat
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 16, 2023
PSMA PET/CT for Assessment of Recurrent Prostate Cancer
Recruiting
- Prostatic Neoplasms
- Prostate Cancer
- PSMA PET/CT scan
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 15, 2021
Prostate Cancer, Prostate Cancer Metastatic, Prostatic Tumor Trial in Vancouver (18F-DCFPyL PET/CT scan, Placebo drink, MSG
Completed
- Prostate Cancer
- +2 more
- 18F-DCFPyL PET/CT scan
- +2 more
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 15, 2021
Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate
Active, not recruiting
- Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
- +8 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Feb 10, 2022
Prostate-Specific Membrane Antigen PET Scans in People Prostate
Recruiting
- Prostate Cancer
- +4 more
- 18F-DCFPyL-iPSMA
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 29, 2022
Metastatic Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection, 18F-NaF)
Completed
- Metastatic Prostate Cancer
- 18F-DCFPyL Injection
- 18F-NaF
-
Baltimore, MarylandJohns Hopkins University
May 5, 2020
Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial in London (PET Scan, [F-18]-DCFPyL Injection, Sodium MRI)
Recruiting
- Prostate Cancer
- +2 more
- PET Scan
- +3 more
-
London, Ontario, CanadaLondon Health Sciences Centre
Dec 6, 2021
Metastatic Prostate Cancer Trial in New York ([F-18] DCFPyL, PET/CT imaging)
Active, not recruiting
- Metastatic Prostate Cancer
- [F-18] DCFPyL
- PET/CT imaging
-
New York, New YorkColumbia University Irving Medical Center
May 6, 2022
Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)
Recruiting
- Prostate Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 2, 2023
Localized Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL)
Recruiting
- Localized Prostate Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Prostate Carcinoma Trial in Duarte (procedure, other, device)
Recruiting
- Prostate Carcinoma
- Computed Tomography
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)
Not yet recruiting
- Prostate Cancer
- Newly-Diagnosed Prostate Cancer
- (no location specified)
Nov 3, 2023
Prostate Cancer Trial in Pittsburgh (18F-DCFPyL)
Active, not recruiting
- Prostate Cancer
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 8, 2022
Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Not yet recruiting
- Prostate Cancer
- Biochemically Recurrent
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Schwannomas, Malignant Tumors Trial in Baltimore (18F-DCFPyL Injection)
Completed
- Schwannomas
- Malignant Tumors
- 18F-DCFPyL Injection
-
Baltimore, MarylandJohns Hopkins University
Jan 9, 2023